rood blauwe elepsis logo Belegger.nl

Woensdag 3 Juni

6 Posts
| Omlaag ↓
  1. [verwijderd] 3 juni 2009 16:56
    geen idee, het is niet alleen citi, maar de gehele financiele markt in de US.

    conversie prijs is 3.25 en misschien is er al wat bekend, maar nog niet officieel.

    EDIT:

    en de verwijdering uit de dow jones heeft toch nog effect op de koers.
    omdat de index de onderliggende Citi aandelen dumpt om travelers ervoor in te kopen.

    ik wilde maandag nog rond de 3.70 verkopen, maar goed.
  2. Alles kwijt 3 juni 2009 19:28
    Na het dieptepunt van vandaag op 3,32 heb ik (toen een stijgende lijn zich begon af te tekenen) bijgekocht op 3,36.
    Inzet verdubbelen heet dat.
    Rien ne va plus. Faites vos jeux. Nu niet meer inzetten.
  3. [verwijderd] 3 juni 2009 21:17
    niet verkeerd. dit zal tegen dinsdag volgende week tegen de $5 aanlopen. zo vaak gedacht om boven de 3.70/80/90 te verkopen en op dit moment te wachten en terug te kopen.

    ik leer..
  4. [verwijderd] 3 juni 2009 22:07
    Tsja, uitspraken Bernanke vallen hard.

    En dan nog dit:

    Bank credit risk falls to pre-Lehman bankruptcy levelsBy: AFX | 03 Jun 2009 | 12:35 PM ET Text Size NEW YORK, June 3 (Reuters) - Concerns about counterparty risk of large banks has fallen to the lowest levels since Lehman Brothers failed in September as successful bank capital raising efforts assuaged investor fears, according to a credit default swap index. The CDR Counterparty Risk Index, which measures the average credit spread of the 14 largest credit derivative dealers, fell 10 percent this week to close at 135 basis points on Tuesday, according to Credit Derivatives Research, which manages the index. This is the tightest level since September 10, 2008, which was 6 days before Lehman filed for bankruptcy. "As US banks continue to take advantage of the unprecedented strength in equity and credit markets to raise both equity and debt capital, investors marked down their default risk significantly," Tim Backshall, chief strategist at Credit Derivatives Research said in a release on Wednesday. Banks have been raising capital as they seek to extricate themselves from Washington's grip. Bank of America, for example, said it has raised close to $33 billion since early May, including $7 billion over six days, closing nearly all of the $33.9 billion capital shortfall that regulators found through its "stress test." For details, see Citigroup was the only bank in the counterparty index that saw its credit spreads widen this week, and its remains significantly wider than its peers, Credit Derivatives Research said. Credit default swaps insuring Citigroup's debt are trading with a spread of around 350 basis points, which is 150 basis points wider than swaps protecting the legacy of debt of Merrill Lynch, the next riskiest bank in the index, CDR said. Credit default swaps are used to hedge against the risk of a borrower defaulting on their debt or to speculate on their credit quality. Widening spreads indicate higher perceptions of default risk. Citigroup's spread movement "is interesting since it remains the most implicitly government-backed of the major financials in the US," Backshall said. "The fact that (Citigroup's) stock also fell the most of the Counterparty Risk Index members this week reflects investor concern that Citi's weakness is systemic and that it is unlikely to earn or self-fund its way out of this situation," he added. Citigroup's shares have fallen to $3.39 on Wednesday from a close of $3.74 on Friday. Banks included in the index are Bank of America, BNP Paribas, Barclays Bank Plc, Citigroup, Credit Suisse Group, Deutsche Bank AG, Dresdner Bank AG, Goldman Sachs, HSBC Bank Plc, JPMorgan, Merrill Lynch, Morgan Stanley, Royal Bank of Scotland Group and UBS AG. (Reporting by Karen Brettell; Editing by Diane Craft) Keywords: BANK SWAPS/ (karen.brettell@thomsonreuters.com; +1 646 223 6274; Reuters Messaging: karen.brettell.reuters.com@reuters.net ) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.

    The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

    Ben heel benieuwd wat Citi volgende week gaat doen? Gaan we eerst terug naar de 3? Citi was steeds erg stabiel. Nu flinke dalingen achter elkaar.
6 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.101
AB InBev 2 5.529
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.889
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.789
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.772
Aedifica 3 925
Aegon 3.258 322.986
AFC Ajax 538 7.088
Affimed NV 2 6.298
ageas 5.844 109.897
Agfa-Gevaert 14 2.060
Ahold 3.538 74.343
Air France - KLM 1.025 35.239
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.046
Alfen 16 25.060
Allfunds Group 4 1.511
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 408
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.574
AMG 971 134.063
AMS 3 73
Amsterdam Commodities 305 6.740
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.028
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.789
Arcelor Mittal 2.034 320.872
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.341
Aroundtown SA 1 221
Arrowhead Research 5 9.749
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.558
ASML 1.766 109.375
ASR Nederland 21 4.503
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.726
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.412